ロード中...
Putting the brakes on BTLA in T cell–mediated cancer immunotherapy
Attenuating coinhibitory molecules for the treatment of cancer is gaining a great deal of attention as a strategy for immunotherapy. The B and T lymphocyte attenuator (BTLA, CD272) is a novel coinhibitory molecule structurally and functionally related to CTLA-4 and PD-1. A study in this issue of the...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2798708/ https://ncbi.nlm.nih.gov/pubmed/20038807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI41811 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|